跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,832 条关于
“KRAS(G12C)”
全部
1,832
临床试验
1,157
药物
235
机构
1
资讯
439
2年前
Glecirasib Shows Promise as Novel KRAS G12C Inhibitor in Solid Tumors
4年前
FDA Approves Sotorasib for KRAS G12C Mutated Metastatic NSCLC
上个月
KRAS G12C: From 'Undruggable' to Druggable with Sotorasib and Adagrasib
2年前
Jacobio Pharma's Glecirasib Shows Promise in KRAS G12C-Mutated NSCLC
2年前
Glecirasib Shows Promise in Pancreatic Cancer and Other Solid Tumors at ASCO GI 2024
去年
FDA Approves Sotorasib Plus Panitumumab for KRAS G12C-Mutated Metastatic Colorectal Cancer
9个月前
Garsorasib Shows 45.5% Response Rate in KRAS G12C-Mutated Pancreatic Cancer Patients
去年
FDA Approves Lumakras and Vectibix Combination for KRAS G12C-Mutated Metastatic Colorectal Cancer
去年
RMC-9805 Demonstrates Promising Activity in KRAS G12D-Mutated Pancreatic Cancer
111年前
D3Bio's Novel KRAS-G12C Inhibitor Shows Promising Results in Phase 1 Cancer Trial
第 1 页,共 44 页
上一页
下一页